Effective Jan. 1, 2018, British Columbians at high risk of HIV infection will be able to receive pre-exposure prophylaxis (PrEP), a daily oral antiretroviral medication that prevents new HIV infection, at no cost.
Health Minister Adrian Dix says the government is committed to helping fight the spread of HIV/AIDS and supporting people as they take action to protect themselves from the virus. T
The drug will be available through the BC Centre for Excellence’s HIV Drug Treatment program, which is funded by the Ministry of Health through the B.C. PharmaCare program.
“B.C. has led the country and the world on efforts to control HIV and AIDS over the last three decades with the development and implementation of the made-in-B.C. Treatment as Prevention strategy. The addition of PrEP and expansion of post-exposure prophylaxis (PEP) to our Treatment as Prevention strategy has the potential to further accelerate the decline of new HIV infections in the province,” said Dr. Julio Montaner, director, BC Centre for Excellence in HIV/AIDS.
Daily use of PrEP is recommended by the World Health Organization and the BC Centre for Excellence in HIV/AIDS as an effective method to prevent HIV in people at risk of infection. It is part of a suite of tools to prevent new HIV infections, including use of condoms and sterile drug use equipment, and other risk-reduction services and supports.
People at risk include men and transwomen who have sex with men, people who inject drugs, and people who have sex with individuals living with HIV.
In August 2016, the Common Drug Review recommended PrEP for coverage, contingent in part on a lower price for the drug Truvada being secured. This condition has been met through the availability of generic Truvada.
People interested in accessing it should talk to their health-care provider.
While HIV/AIDS-related deaths in B.C. have decreased by more than 90% since 1996, new cases of HIV continue to emerge. In 2015, there were 5.1 new diagnoses of HIV per every 100,000 people in British Columbia.